Compare RGEN & TRNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGEN | TRNO |
|---|---|---|
| Founded | 1981 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 6.8B |
| IPO Year | 1995 | 2009 |
| Metric | RGEN | TRNO |
|---|---|---|
| Price | $126.57 | $64.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 12 |
| Target Price | ★ $167.67 | $67.83 |
| AVG Volume (30 Days) | ★ 928.9K | 879.0K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.21% |
| EPS Growth | ★ 286.96 | 103.65 |
| EPS | 0.15 | ★ 0.66 |
| Revenue | $141,236,000.00 | ★ $476,383,000.00 |
| Revenue This Year | $14.30 | $8.42 |
| Revenue Next Year | $14.52 | $9.10 |
| P/E Ratio | $880.13 | ★ $97.50 |
| Revenue Growth | ★ 35.10 | 24.51 |
| 52 Week Low | $100.99 | $53.00 |
| 52 Week High | $175.77 | $67.83 |
| Indicator | RGEN | TRNO |
|---|---|---|
| Relative Strength Index (RSI) | 51.33 | 48.67 |
| Support Level | $111.09 | $63.78 |
| Resistance Level | $131.53 | $67.18 |
| Average True Range (ATR) | 5.57 | 1.56 |
| MACD | 0.27 | -0.10 |
| Stochastic Oscillator | 42.86 | 44.73 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
Terreno Realty Corp is a real estate investment trust engaged in acquiring, owning, and operating industrial real estate in six coastal U.S. markets: Los Angeles, Northern New Jersey/New York City, San Francisco Bay Area, Seattle, Miami, and Washington, D.C. The company invests in several types of industrial real estate, including warehouse/distribution, flex (including light industrial and research and development), transshipment, and improved land.